long-arrow-pointing-to-left linkedin twitter facebook mail
BATTELLE

The Battelle Sematrix™ Advantage

Sematrix is a complex linked set of computational processes, including NLP, that convert textual narrative into a form that can be interrogated and analyzed, and to some extent understood, by means of both predicate logic and statistical analysis.

question

what’s inside

Each year, researchers add hundreds of thousands of articles to the peer-reviewed literature. Findings from most studies will take 17 years or more to translate into clinical practice (1). Few scientists expect their individual works to result in practice changes, but most expect that their work will contribute to the knowledge base that informs practice, as well as informing future research and policymaking. Evidence-based practice (EBP) changes require a time-consuming and labor-intensive process of selecting, analyzing and synthesizing the evidence necessary to address critical clinical questions. The results of this process intend to help busy clinicians stay abreast of current evidence.

Download our white paper and learn the advantage that Sematrix™ has to offer:

Conversion of textual content into a large collection of fine-grained axiomatic triples

Supports investigators’ engagement in comprehensive, efficient, and cost-effective literature reviews

Sematrix locates, extracts and organizes the best available knowledge

Ability to convert textual narrative into a form that can be interrogated and analyzed

bg-form

apply what you learn

Sematrix represents the knowledge from scientific and technical documents in a way that allows investigators to identify and map similar research, identify gaps in research conducted within a given field, or map relationships among certain authors or groups.

Just provide a bit of information on the right and you can learn more with our white paper: The Battelle Sematrix Advantage

get the white paper

This field is required Would you like to receive updates from Battelle?

Please refer to our PRIVACY POLICY for more information.